Of participants with a variant in plasma and/or tumour, 24 had a mutation in TP53, including 9 of the 12 concordant variants, 71% of the plasma only variants, and 51% of the tumour only variants (Fig. 1d and Supplementary Fig. 1b). The gene discussed is TP53; the disease is neoplasm.